Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $39.07 in the prior trading day, MoonLake Immunotherapeutics (NASDAQ: MLTX) closed at $36.35, down -6.96%. In other words, the price has decreased by -$6.96 from its previous closing price. On the day, 0.5 million shares were traded. MLTX stock price reached its highest trading level at $39.21 during the session, while it also had its lowest trading level at $36.34.
Ratios:
Our goal is to gain a better understanding of MLTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 21.11 and its Current Ratio is at 21.11. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on March 18, 2025, initiated with a Outperform rating and assigned the stock a target price of $67.
On January 17, 2025, Goldman Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $62 to $82.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 04 ’24 when BVF PARTNERS L P/IL sold 2,000,000 shares for $50.00 per share. The transaction valued at 100,003,200 led to the insider holds 1,287,768 shares of the business.
Sturge Simon sold 171,000 shares of MLTX for $9,186,120 on Oct 04 ’24. The Director now owns 171,980 shares after completing the transaction at $53.72 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MLTX now has a Market Capitalization of 2300326144 and an Enterprise Value of 1861695488.
Stock Price History:
The Beta on a monthly basis for MLTX is 1.31, which has changed by -0.2092669 over the last 52 weeks, in comparison to a change of 0.08089435 over the same period for the S&P500. Over the past 52 weeks, MLTX has reached a high of $58.26, while it has fallen to a 52-week low of $36.52. The 50-Day Moving Average of the stock is -13.34%, while the 200-Day Moving Average is calculated to be -22.12%.
Shares Statistics:
The stock has traded on average 440.25K shares per day over the past 3-months and 553340 shares per day over the last 10 days, according to various share statistics. A total of 63.08M shares are outstanding, with a floating share count of 52.78M. Insiders hold about 16.60% of the company’s shares, while institutions hold 100.17% stake in the company. Shares short for MLTX as of 1741910400 were 7239529 with a Short Ratio of 16.44, compared to 1739491200 on 8045590. Therefore, it implies a Short% of Shares Outstanding of 7239529 and a Short% of Float of 27.61.
